QT
NUVB icon

Quantbot Technologies’s Nuvation Bio NUVB Stock Holding History

Quantbot Technologies’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.7K Buy
+9,280
New +$45.4K ﹤0.01% 1627
2026
Q1 		– Sell
-1,695
Closed -$15.2K – 2024
2025
Q4 		$15.2K Buy
+1,695
New +$10.5K ﹤0.01% 1580
2025
Q2 		– Sell
-23,897
Closed -$42.1K – 1848
2025
Q1 		$42.1K Sell
23,897
-7,448
-24% -$17K ﹤0.01% 1333
2024
Q4 		$83.4K Sell
31,345
-40,881
-57% -$105K ﹤0.01% 1236
2024
Q3 		$165K Buy
+72,226
New +$220K 0.01% 1061
2022
Q4 		– Sell
-7,150
Closed -$16K – 1978
2022
Q3 		$16K Sell
7,150
-19,487
-73% -$55.6K ﹤0.01% 1380
2022
Q2 		$86K Buy
26,637
+13,254
+99% +$57.8K 0.01% 1188
2022
Q1 		$70K Buy
13,383
+7,981
+148% +$44.8K 0.01% 1119
2021
Q4 		$45K Buy
+5,402
New +$49.6K ﹤0.01% 1052
2021
Q3 		– Sell
-4,495
Closed -$41K – 1774
2021
Q2 		$41K Buy
4,495
+3,179
+242% +$36.3K ﹤0.01% 1104
2021
Q1 		$13K Buy
+1,316
New +$14.7K ﹤0.01% 1224

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Quantbot Technologies's NUVB Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Nuvation Bio (NUVB) in Q2 2026: 9,280 shares worth $52.7K. The stake represents ﹤0.01% of the portfolio and ranks #1627 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in NUVB as recently as Q4 2025.

Quantbot Technologies first reported a position in NUVB in Q1 2021 and has held it in 11 quarters since. The position peaked at $165K in Q3 2024. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Quantbot Technologies held 9,280 shares of Nuvation Bio worth $52.7K as of Q2 2026.
  • Nuvation Bio was a new Quantbot Technologies position in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1627 holding.
  • Quantbot Technologies first reported a position in Nuvation Bio in Q1 2021 and has held it in 11 quarters since.
  • Quantbot Technologies's Nuvation Bio position peaked at $165K in Q3 2024.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.